Our findings for the protective roles of CETP for diet-induced fatty liver and insulin resistance specific in females may provide insight to explain why most clinical trials with CETP inhibitors failed in improving the risks for cardiovascular disease. The gene discussed is CETP; the disease is Insulin resistance.